• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在CHO细胞中稳定过表达天然和人工miRNA以产生不同岩藻糖基化的抗体。

Stable overexpression of native and artificial miRNAs for the production of differentially fucosylated antibodies in CHO cells.

作者信息

Schlossbauer Patrick, Naumann Lukas, Klingler Florian, Burkhart Madina, Handrick René, Korff Kathrin, Neusüß Christian, Otte Kerstin, Hesse Friedemann

机构信息

Institute for Applied Biotechnology University of Applied Sciences Biberach Biberach Germany.

Department of Chemistry Aalen University Aalen Germany.

出版信息

Eng Life Sci. 2024 Apr 1;24(6):2300234. doi: 10.1002/elsc.202300234. eCollection 2024 Jun.

DOI:10.1002/elsc.202300234
PMID:38845814
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11151017/
Abstract

Cell engineering strategies typically rely on energy-consuming overexpression of genes or radical gene-knock out. Both strategies are not particularly convenient for the generation of slightly modulated phenotypes, as needed in biosimilar development of for example differentially fucosylated monoclonal antibodies (mAbs). Recently, transiently transfected small noncoding microRNAs (miRNAs), known to be regulators of entire gene networks, have emerged as potent fucosylation modulators in Chinese hamster ovary (CHO) production cells. Here, we demonstrate the applicability of stable miRNA overexpression in CHO production cells to adjust the fucosylation pattern of mAbs as a model phenotype. For this purpose, we applied a miRNA chaining strategy to achieve adjustability of fucosylation in stable cell pools. In addition, we were able to implement recently developed artificial miRNAs (amiRNAs) based on native miRNA sequences into a stable CHO expression system to even further fine-tune fucosylation regulation. Our results demonstrate the potential of miRNAs as a versatile tool to control mAb fucosylation in CHO production cells without adverse side effects on important process parameters.

摘要

细胞工程策略通常依赖于耗能的基因过表达或彻底的基因敲除。这两种策略对于产生微调的表型(如在生物类似药开发中,例如差异岩藻糖基化单克隆抗体(mAb)的开发中所需要的)来说都不是特别方便。最近,已知作为整个基因网络调节因子的瞬时转染小非编码微RNA(miRNA),已成为中国仓鼠卵巢(CHO)生产细胞中有效的岩藻糖基化调节剂。在这里,我们证明了在CHO生产细胞中稳定过表达miRNA以调节mAb的岩藻糖基化模式作为模型表型的适用性。为此,我们应用了一种miRNA串联策略,以实现稳定细胞库中岩藻糖基化的可调节性。此外,我们能够将基于天然miRNA序列的最新开发的人工miRNA(amiRNA)应用于稳定的CHO表达系统,以进一步微调岩藻糖基化调节。我们的结果证明了miRNA作为一种通用工具来控制CHO生产细胞中mAb岩藻糖基化的潜力,而不会对重要的工艺参数产生不利的副作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5417/11151017/543e859b1cc7/ELSC-24-2300234-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5417/11151017/e4cf38199a04/ELSC-24-2300234-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5417/11151017/537855d1072c/ELSC-24-2300234-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5417/11151017/1c6879d051a2/ELSC-24-2300234-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5417/11151017/d5376214ee5b/ELSC-24-2300234-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5417/11151017/a23675ed2447/ELSC-24-2300234-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5417/11151017/543e859b1cc7/ELSC-24-2300234-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5417/11151017/e4cf38199a04/ELSC-24-2300234-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5417/11151017/537855d1072c/ELSC-24-2300234-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5417/11151017/1c6879d051a2/ELSC-24-2300234-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5417/11151017/d5376214ee5b/ELSC-24-2300234-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5417/11151017/a23675ed2447/ELSC-24-2300234-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5417/11151017/543e859b1cc7/ELSC-24-2300234-g003.jpg

相似文献

1
Stable overexpression of native and artificial miRNAs for the production of differentially fucosylated antibodies in CHO cells.在CHO细胞中稳定过表达天然和人工miRNA以产生不同岩藻糖基化的抗体。
Eng Life Sci. 2024 Apr 1;24(6):2300234. doi: 10.1002/elsc.202300234. eCollection 2024 Jun.
2
A novel system for glycosylation engineering by natural and artificial miRNAs.一种通过天然和人工 miRNA 进行糖基化工程的新系统。
Metab Eng. 2023 May;77:53-63. doi: 10.1016/j.ymben.2023.03.004. Epub 2023 Mar 9.
3
Stable miRNA overexpression in human CAP cells: Engineering alternative production systems for advanced manufacturing of biologics using miR-136 and miR-3074.人 CAP 细胞中稳定的 miRNA 过表达:利用 miR-136 和 miR-3074 工程替代生产系统用于生物制剂的高级制造。
Biotechnol Bioeng. 2018 Aug;115(8):2027-2038. doi: 10.1002/bit.26715. Epub 2018 May 3.
4
miRNA engineering of CHO cells facilitates production of difficult-to-express proteins and increases success in cell line development.对中国仓鼠卵巢细胞进行微小RNA工程改造有助于生产难以表达的蛋白质,并提高细胞系开发的成功率。
Biotechnol Bioeng. 2017 Jul;114(7):1495-1510. doi: 10.1002/bit.26280. Epub 2017 Apr 18.
5
Development of a pre-glycoengineered CHO-K1 host cell line for the expression of antibodies with enhanced Fc mediated effector function.开发预糖基化 CHO-K1 宿主细胞系用于表达具有增强 Fc 介导效应功能的抗体。
MAbs. 2018 Feb/Mar;10(2):290-303. doi: 10.1080/19420862.2017.1405203. Epub 2017 Dec 12.
6
A functional high-content miRNA screen identifies miR-30 family to boost recombinant protein production in CHO cells.一项功能性高内涵miRNA筛选鉴定出miR-30家族可提高CHO细胞中重组蛋白的产量。
Biotechnol J. 2014 Oct;9(10):1279-92. doi: 10.1002/biot.201400306. Epub 2014 Aug 26.
7
Computational identification of microRNA gene loci and precursor microRNA sequences in CHO cell lines.CHO 细胞系中 microRNA 基因座和前体 microRNA 序列的计算鉴定。
J Biotechnol. 2012 Apr 15;158(3):151-5. doi: 10.1016/j.jbiotec.2012.01.019. Epub 2012 Jan 25.
8
Developing microRNAs as engineering tools to modulate monoclonal antibody galactosylation.开发 microRNAs 作为工程工具调节单克隆抗体半乳糖基化。
Biotechnol Bioeng. 2024 Apr;121(4):1355-1365. doi: 10.1002/bit.28616. Epub 2023 Dec 11.
9
Stable microRNA expression enhances therapeutic antibody productivity of Chinese hamster ovary cells.稳定的 microRNA 表达增强了中国仓鼠卵巢细胞的治疗性抗体生产能力。
Metab Eng. 2013 Nov;20:157-66. doi: 10.1016/j.ymben.2013.10.005. Epub 2013 Oct 18.
10
Stable overexpression of miR-17 enhances recombinant protein production of CHO cells.miR-17 的稳定过表达可提高 CHO 细胞的重组蛋白表达产量。
J Biotechnol. 2014 Apr 10;175(100):38-44. doi: 10.1016/j.jbiotec.2014.01.032. Epub 2014 Feb 8.

本文引用的文献

1
Augmented region of interest for untargeted metabolomics mass spectrometry (AriumMS) of multi-platform-based CE-MS and LC-MS data.基于多平台 CE-MS 和 LC-MS 数据的无靶向代谢组学质谱的增强感兴趣区域 (AriumMS)。
Anal Bioanal Chem. 2023 Jul;415(16):3137-3154. doi: 10.1007/s00216-023-04715-6. Epub 2023 May 25.
2
A novel system for glycosylation engineering by natural and artificial miRNAs.一种通过天然和人工 miRNA 进行糖基化工程的新系统。
Metab Eng. 2023 May;77:53-63. doi: 10.1016/j.ymben.2023.03.004. Epub 2023 Mar 9.
3
Biopharmaceutical benchmarks 2022.
2022 年生物制药基准报告
Nat Biotechnol. 2022 Dec;40(12):1722-1760. doi: 10.1038/s41587-022-01582-x.
4
Production of afucosylated antibodies in CHO cells by coexpression of an anti-FUT8 intrabody.通过共表达抗-FUT8 内抗体在 CHO 细胞中生产去岩藻糖基化抗体。
Biotechnol Bioeng. 2022 Aug;119(8):2206-2220. doi: 10.1002/bit.28127. Epub 2022 May 14.
5
The Effect of microRNA on the Production of Recombinant Protein in CHO Cells and its Mechanism.微小RNA对CHO细胞中重组蛋白产生的影响及其机制
Front Bioeng Biotechnol. 2022 Mar 21;10:832065. doi: 10.3389/fbioe.2022.832065. eCollection 2022.
6
Strategies to control therapeutic antibody glycosylation during bioprocessing: Synthesis and separation.在生物工艺过程中控制治疗性抗体糖基化的策略:合成与分离。
Biotechnol Bioeng. 2022 Jun;119(6):1343-1358. doi: 10.1002/bit.28066. Epub 2022 Feb 28.
7
High-throughput glycosylation analysis of intact monoclonal antibodies by mass spectrometry coupled with capillary electrophoresis and liquid chromatography.通过与毛细管电泳和液相色谱联用的质谱法对完整单克隆抗体进行高通量糖基化分析。
J Sep Sci. 2022 Jun;45(12):2034-2044. doi: 10.1002/jssc.202100865. Epub 2022 Jan 27.
8
Effective tools for RNA-derived therapeutics: siRNA interference or miRNA mimicry.用于 RNA 治疗的有效工具:siRNA 干扰或 miRNA 模拟。
Theranostics. 2021 Aug 11;11(18):8771-8796. doi: 10.7150/thno.62642. eCollection 2021.
9
Comparison of two glycoengineering strategies to control the fucosylation of a monoclonal antibody.比较两种糖基化工程策略以控制单克隆抗体的岩藻糖基化。
J Biotechnol. 2020;324S:100015. doi: 10.1016/j.btecx.2020.100015. Epub 2020 Feb 20.
10
Cellular Fucosylation Inhibitors Based on Fluorinated Fucose-1-phosphates*.基于氟化果糖-1-磷酸的细胞岩藻糖基化抑制剂*。
Chemistry. 2021 Feb 24;27(12):4022-4027. doi: 10.1002/chem.202005359. Epub 2021 Feb 2.